Vision Screeners Global Market Report 2025

The vision screeners market size has grown strongly in recent years. It will grow from $0.7 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. This growth in the historical period was driven by increasing recognition of childhood vision issues, the expansion of school-based screening initiatives, an aging global population, enhanced eye care programs, and elevated levels of public health investments.

The vision screeners market size is expected to see strong growth in the next few years. It will grow to $1.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth include the broader implementation of screening programs in educational and workplace settings, growing adoption of telehealth solutions, heightened emphasis on preventive healthcare, rising demand from occupational vision screening, and an upsurge in myopia and vision problems linked to prolonged screen use. Key trends projected during this period include the adoption of AI-driven technologies, enhanced device portability and compactness, movement toward non-invasive and user-centric tools, digital and AI-enabled vision testing solutions, and collaborations between technology firms and medical service providers.

The increasing prevalence of vision-related disorders is expected to drive the growth of the vision screeners market. Vision-related disorders refer to medical conditions that affect the eyes or the visual system, leading to impaired sight or difficulty processing visual information. The rise in these disorders is primarily due to aging populations, as the risk of conditions such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy increases significantly with age. This results in a higher incidence of these conditions among older adults. Vision screeners play a crucial role in detecting such disorders early by identifying visual impairments before they worsen. This early detection enables timely intervention and treatment, which reduces the risk of long-term complications, supports improved eye health outcomes, and enhances the overall quality of life through better vision care. For example, in September 2023, the Association of Optometrists, a UK-based representative membership organization, reported that England recorded 22,552 new certifications for vision impairment in 2022. Among these, 1,344 were due to diabetic eye disease, 3,614 were related to glaucoma, and 10,865 were attributed to age-related macular degeneration. As a result, the growing prevalence of vision-related disorders is fueling the demand for vision screeners.

Companies operating in the vision screeners market are increasingly focusing on integrating advanced technologies such as virtual reality (VR) to transform preliminary vision assessments. VR technology creates immersive, interactive 3D environments experienced through headsets, which enhances user engagement and testing accuracy. This approach allows for simulating a variety of visual scenarios and testing conditions in a controlled, engaging setting, enabling precise assessment of visual acuity, depth perception, and eye coordination. For instance, in September 2024, Zenni Optical Inc., a US-based optical products manufacturer, launched the VR Vision Screener, an innovative and user-friendly device that uses VR to conduct fast, clinically validated vision screenings. The tool evaluates clarity, color, and depth perception in about five minutes and is designed to complement - rather than replace - traditional eye exams. It is compatible with leading headsets such as the Meta Quest 3. This VR-based screener aims to enhance accessibility and efficiency in vision care, particularly in schools and clinics, by serving as a bridge between initial screenings and comprehensive eye evaluations.

In March 2022, Digital Diagnostics Inc., a US-based healthcare technology company specializing in autonomous AI diagnostics, partnered with Baxter International Inc. to expand access to high-quality, point-of-care diabetic eye exams. The partnership integrates Digital Diagnostics’ autonomous AI software with Baxter’s retinal imaging technology to assist frontline healthcare providers in detecting and treating vision-threatening conditions at an early stage. Baxter International Inc. is a US-based healthcare company offering a wide range of essential medical devices, pharmaceuticals, and diagnostics.

Major players in the vision screeners market are Baxter International Inc., Visibly Inc., Essilor Instruments USA, Amplivox Sound Systems L.L.C., Oculus Inc., Optomed Oyj, Good-Lite Co., Visionix USA Inc., EyeQue Inc., Tomey Corporation, Stereo Optical Company Inc., EyeNetra Inc., Vmax Vision Inc., Frastema Ophthalmics Inc., Plusoptix Inc., FIM Medical SAS, Titmus LLC, Smart Vision Labs Inc., NIDEK Co. Ltd., and Adaptica S.r.l.

North America was the largest region in the vision screeners market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vision screeners report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vision screeners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vision screeners are diagnostic tools or instruments designed to identify visual impairments or eye-related conditions, especially in their early stages and among target groups like children and older adults. These devices evaluate several aspects of vision, including acuity, depth perception, color vision, and refractive errors, to detect potential concerns that may need follow-up care from an eye health specialist.

Vision screeners are available in various forms, including handheld, stationary, portable, and smartphone-based models. Handheld vision screeners are compact and allow for rapid, on-the-go vision testing with the ability to digitally store results, thereby enhancing access and efficiency in vision care. These devices incorporate technologies such as autorefractors, vision testing software, ophthalmic imaging systems, and telehealth platforms. They are used across several applications such as pediatric, adult, and geriatric vision screening, as well as occupational health assessments. Distribution channels include direct sales, online platforms, distributors and retailers, and healthcare providers. The main end users are hospitals, homecare environments, specialized clinics, rehabilitation centers, and ambulatory surgical centers.

The vision screeners market research report is one of a series of new reports that provides vision screeners market statistics, including the vision screeners industry global market size, regional shares, competitors with the vision screeners market share, detailed vision screeners market segments, market trends, and opportunities, and any further data you may need to thrive in the vision screeners industry. These vision screeners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vision screeners market consists of revenues earned by entities by providing services such as vision testing, early detection of eye disorders, school and workplace screening programs, and mobile screening units. The market value includes the value of related goods sold by the service provider or contained within the service offering. The vision screeners market also consists of sales of products, including autorefractors, visual acuity charts, photoscreeners, and digital eye charts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.